We are live on
!
Find out more
ACM
AIGH Capital Management Portfolio holdings
AUM
$1.59B
1-Year Est. Return
855.46%
This Fund
S&P 500
This Quarter
Est. Return
+7.49%
1 Year Est. Return
+855.46%
3 Year Est. Return
+3,007.26%
5 Year Est. Return
+4,204.76%
10 Year Est. Return
–
AUM
$322M
AUM Growth
-$58.3M
(-15%)
Cap. Flow
-$59.9M
Cap. Flow
% of AUM
-18.61%
Top 10 Holdings %
Top 10 Hldgs %
67.93%
Holding
59
New
12
Increased
10
Reduced
16
Closed
5
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
indie Semiconductor
INDI
|
+$10.8M |
| 2 |
TELA Bio
TELA
|
+$10.1M |
| 3 |
Materion
MTRN
|
+$4.95M |
| 4 |
Aviat Networks
AVNW
|
+$3.84M |
| 5 |
APEN
Apollo Endosurgery, Inc.
APEN
|
+$2.82M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CYBE
Cyberoptics Corp
CYBE
|
+$17.8M |
| 2 |
SCPH
scPharmaceuticals
SCPH
|
+$3.15M |
| 3 |
Everspin Technologies
MRAM
|
+$2.74M |
| 4 |
Ardelyx
ARDX
|
+$2.18M |
| 5 |
AVEO
AVEO Pharmaceuticals, Inc.
AVEO
|
+$1.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 37.83% |
| 2 | Healthcare | 28.66% |
| 3 | Materials | 6% |
| 4 | Industrials | 1.41% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
51
Rezolute
RZLT
$452M
| $33K | 0.01% |
11,866
-72,917
| -86% | -$211K |
|
|
CYTHW
52
CALL
DELISTED
Cyclo Therapeutics, Inc. Warrant
CYTHW
| $26K | 0.01% |
73,736
-220,695
| -75% | -$114K |
|
|
PRBM.WS
53
DELISTED
Parabellum Acquisition Corp. Redeemable Warrants, each exercisable for one share of Common Stock at an exercise price of $11.50 per share
PRBM.WS
| $8K | ﹤0.01% |
+450,214
| New | +$33.9K |
|
|
PRBM.WS
54
CALL
DELISTED
Parabellum Acquisition Corp. Redeemable Warrants, each exercisable for one share of Common Stock at an exercise price of $11.50 per share
PRBM.WS
| $3K | ﹤0.01% |
139,072
-450,214
| -76% | -$33.9K |
|
55
Bridgeline Digital
BLIN
$14.4M
| – | – |
-178,003
| Closed | -$214K |
|
56
Babcock & Wilcox
BW
$1.39B
| – | – |
-163,199
| Closed | -$984K |
|
|
SVRE
57
CALL
SaverOne 2014 Ltd
SVRE
$6.15M
| – | – |
-66
| Closed | -$200K |
|
|
SVRE
58
SaverOne 2014 Ltd
SVRE
$6.15M
| – | – |
-52
| Closed | -$1.03M |
|
|
CYBE
59
DELISTED
Cyberoptics Corp
CYBE
| – | – |
-509,917
| Closed | -$17.8M |
|
Similar funds
VNT
GWANC
NCL
DG
SS
LCM
LCM
FDCP
AIGH Capital Management's Q3 2022 Portfolio in Review
As of Q3 2022, AIGH Capital Management held 59 positions worth $322M, down 15% from $380M the previous quarter. Its ten largest holdings account for 68% of the portfolio.
AIGH Capital Management withdrew a net $59.9M in Q3 2022, closing 5 positions and reducing 16 holdings. Its most notable exit was Cyberoptics Corp, an estimated $17.8M position sold in full.
By sector, the portfolio is most concentrated in Technology at 38% of assets, up from 30% a quarter earlier, followed by Healthcare and Materials.
Against the trend, AIGH Capital Management opened a new position in indie Semiconductor worth $10.6M.
- AIGH Capital Management's largest Q3 2022 buy was indie Semiconductor: 1,452,766 shares worth $10.6M.
- AIGH Capital Management added most to TELA Bio in Q3 2022, an estimated $10.1M increase.
- AIGH Capital Management's biggest Q3 2022 reduction was scPharmaceuticals, cutting an estimated $3.15M.
- AIGH Capital Management fully exited Cyberoptics Corp in Q3 2022, selling an estimated $17.8M.
- AIGH Capital Management's ten largest holdings make up 68% of its $322M portfolio in Q3 2022.
- AIGH Capital Management opened 12 new positions and closed 5 in Q3 2022.
- AIGH Capital Management's portfolio value fell 15% quarter-over-quarter to $322M.
Based on AIGH Capital Management's 13F filing for Q3 2022, filed 14 Nov 2022.